Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)
A Japanese retrospective study (J-DART2) reports treatment outcomes for renal cell carcinoma patients treated with the combination of avelum…
-
EMA approval · 2025-03-28EMA Authorised: Nexavar (sorafenib) — Bayer AG
The EMA authorised Nexavar (sorafenib) for hepatocellular carcinoma and renal cell carcinoma. The decision date was 13 February 2025.
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis
A clinical trial update describing long-term follow-up of immune checkpoint inhibitor–induced ileocolitis and ongoing recruitment for patien…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC. [Phase 1, Phase 2]
A single-center Phase 1/2 trial is evaluating the safety and effects of combining a ketogenic diet with immunotherapy in adults with advance…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Study of Kidney Tumors in Younger Patients
The Children's Oncology Group study of kidney tumors in younger patients is currently active but not recruiting. It covers multiple pediatri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC [Phase 2]
A Phase 2 clinical trial at Peking University First Hospital is evaluating SABR radiation combined with axitinib and toripalimab for recurre…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial) [Phase 2]
A Phase 2 trial of lenvatinib plus pembrolizumab in locally advanced or metastatic non-clear cell renal cell carcinoma was terminated. Resul…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Bilateral Ultrasound Guided Intramuscular Quadratus Lumborum Plane Block Versus Bilateral Lateral Quadratus Lumborum Plane Block in Controlling Postoperative Pain in Cancer Patients Undergoing Open Nephrectomy [NA]
This clinical trial update notes a study comparing bilateral intramuscular and bilateral lateral quadratus lumborum plane blocks for postope…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating atezolizumab in combination with entinostat and bevacizumab in advanced renal cell carcinoma; the study …
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Optimising Renal Tumour Management Through Artificial Intelligence Modules
A clinical trial is evaluating artificial intelligence modules to optimize renal tumour management and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Nivolumab Plus Metformin in Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating nivolumab in combination with metformin for metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. [Phase 1]
This Phase I trial is evaluating the safety and tolerability of LXP1788 Injection in adults with advanced solid tumors and is currently recr…
-
CLINICAL_TRIALS withdrawal · 2025-03-19Clinical Trial Update: A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Pfizer's post-marketing surveillance study of Zirabev to assess safety and effectiveness in domestic cancer patients has been withdrawn.
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
Clinical trial update for a study evaluating renal mass biopsy, PEER, and 99mTc-sestamibi SPECT/CT in patients with localized renal tumors; …
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: The CT-based Deep Learning Model Predicts Complications in Partial Nephrectomy
A completed clinical trial evaluated a CT-based deep learning model for predicting complications during partial nephrectomy. The study popul…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Study of INCB086550 in Select Solid Tumors [Phase 2]
A Phase 2 trial evaluating INCB086550 across select solid tumors, including non-small cell lung cancer and urothelial carcinoma, was termina…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy
A completed clinical trial evaluating nivolumab in metastatic renal cell carcinoma, examining regulatory T cell function, T-cell access, and…
-
EMA approval · 2025-03-10EMA Authorised: Sutent (sunitinib) — Pfizer Limited
Sutent (sunitinib) has been authorised by the EMA with indications for gastrointestinal stromal tumor, renal cell carcinoma, and neuroendocr…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer [Phase 2]
Phase 2 study evaluating high-dose interleukin-2 in combination with stereotactic body radiation therapy for metastatic renal cell carcinoma…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy [Phase 1]
A Phase 1 clinical trial comparing epidural analgesia to intrathecal opioid analgesia for pain management after open nephrectomy, currently …
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating AK104 as monotherapy or in combination with axitinib for advanced/metastatic…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy [Phase 2]
This Phase 2 trial compares a folic acid supplement to placebo for treating mucositis in metastatic renal cell carcinoma patients receiving …
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: TDM for Optimized Outcome in Patients With mRCC.
This entry reports a clinical trial investigating therapeutic drug monitoring to optimize outcomes in patients with metastatic renal cell ca…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pre-incisional ketorolac in surgery for non-small cell lung cancer or renal cell carcinoma has been terminated, wit…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared [NA]
This clinical trial update reports on Nephrogreen, evaluating ex vivo appearances of renal tumors under near-infrared light; the study (NCT0…